Routine Measurements of Factor VIII Activity and Inhibitor Titer in the Presence of Emicizumab Utilizing Anti-Idiotype Monoclonal Antibodies
Journal of Thrombosis and Haemostasis - United Kingdom
doi 10.1111/jth.14135
Full Text
Open PDFAbstract
Available in full text
Date
May 27, 2018
Authors
Publisher
Wiley